Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 25, 2022
Patent Application Number
15337519
Date Filed
October 28, 2016
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to aqueous pharmaceutical compositions comprising a high concentration (i.e., greater than 50 milligrams per milliliter) of adalimumab (including antibody proteins considered or intended as “biosimilar” or “bio-better” variants of commercially available adalimumab) suitable for long-term storage, and methods of manufacture of the compositions; methods of their administration; and articles containing the same.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.